Commonwealth Equity Services
NBSE

Commonwealth Equity Services’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Commonwealth Equity Services’s Portfolio NBSE Stock Details NBSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-30
Closed -$2K – 2835
2018
Q3 		$2K Buy
+30
New +$2.26K ﹤0.01% 2787

Other funds holding NBSE

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
GBA
Garrison Bradford & Associates New York $88.4M AUM 15.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services's NBSE Position: Q4 2018 in Review

Commonwealth Equity Services sold out of NeuBase Therapeutics, Inc. Common Stock (NBSE) in Q4 2018, closing a stake of 30 shares — an estimated $2K sold.

Commonwealth Equity Services first reported a position in NBSE in Q3 2018 and held it in 1 quarter. The position peaked at $2K in Q3 2018. 24 funds tracked by Wall St. Rank hold NBSE as of Q4 2018.

  • Commonwealth Equity Services reported no remaining NeuBase Therapeutics, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Commonwealth Equity Services sold 30 NeuBase Therapeutics, Inc. Common Stock shares in Q4 2018, an estimated $2K.
  • Commonwealth Equity Services first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q3 2018 and held it in 1 quarter.
  • Commonwealth Equity Services's NeuBase Therapeutics, Inc. Common Stock position peaked at $2K in Q3 2018.
  • 24 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q4 2018.

Based on Commonwealth Equity Services's 13F filing for Q4 2018, filed 11 Feb 2019.